British prime minister David Cameron has pledged £150 million ($228 milllion) to set up the UK’s first Dementia Research Institute.
Led by the Medical Research Council, the institute will bring together world-leading experts, universities and organizations to drive forward research and innovation in fighting dementia, said the prime minister as he announced the new initiative.
It will have a central UK hub, with links to universities across the country and will build on the centres of excellence in dementia already operating across the UK.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze